Biotech Values

[iwfal]

Cancer drug costs too high -

The authors are prominent oncologists at M.D. Anderson Cancer Center.

The Zaltrap editorial in the NYT, which was penned by doctors at Sloan Kettering, eventually caused SNY to cut the US price by 50% (#msg-81295132).

Pretty funny given the article posted on this board (or SI) about MD Anderson charging absolutely outrageous prices for medical care.

More seriously after a lot of research on where the money goes the problem is clearly multi-factored - but one of them is US MD salaries going up faster than inflation for a long time (obviously not all docs - but touch labor specialists in particular). Of course that makes the editorial even funnier.

PS This does not mean that I think that drug pricing is reasonable - but it might be wise to avoid throwing rocks if you are an MD at Anderson.